- cafead Jul 19, 2021 at 11:22: PM
via The biotech IPO market continues to charge full-steam ahead, with three more companies submitting their Nasdaq pitches to the SEC late Friday.
The leaders among the pack are Adagio Therapeutics and Castle Creek Biosciences, each penciling in $100 million initially. Following up the rear is Eliem Therapeutics, jotting down $80 million for its raise estimate less than six months after launching out of RA Capital’s incubator.
article source
The leaders among the pack are Adagio Therapeutics and Castle Creek Biosciences, each penciling in $100 million initially. Following up the rear is Eliem Therapeutics, jotting down $80 million for its raise estimate less than six months after launching out of RA Capital’s incubator.
article source